The rights and interests of participants as limits to clinical trials.

R Dal-Ré
{"title":"The rights and interests of participants as limits to clinical trials.","authors":"R Dal-Ré","doi":"10.1016/j.rceng.2024.11.002","DOIUrl":null,"url":null,"abstract":"<p><p>Point-8 of the Declaration of Helsinki requires that the rights and interests of research participants must always prevail over the scientific interests of the research. Recently, it has been proposed that point-8 be modified in the opposite direction, i.e., that it be acceptable for scientific interests to prevail over the interests of the participants. This article argues against this change and uses as an example what happened with the experimental SARS-CoV-2 vaccines versus placebo masked trials. When the high efficacy of the vaccines became evident, the question arose as to what should be done, whether to keep the trials masked until long-term efficacy, immunogenicity and safety data were obtained, or to break the masking and offer participants who received placebo the vaccine that had been shown to be efficacious. The latter was the correct attitude that translated point-8 into practice.</p>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clinica espanola","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.rceng.2024.11.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Point-8 of the Declaration of Helsinki requires that the rights and interests of research participants must always prevail over the scientific interests of the research. Recently, it has been proposed that point-8 be modified in the opposite direction, i.e., that it be acceptable for scientific interests to prevail over the interests of the participants. This article argues against this change and uses as an example what happened with the experimental SARS-CoV-2 vaccines versus placebo masked trials. When the high efficacy of the vaccines became evident, the question arose as to what should be done, whether to keep the trials masked until long-term efficacy, immunogenicity and safety data were obtained, or to break the masking and offer participants who received placebo the vaccine that had been shown to be efficacious. The latter was the correct attitude that translated point-8 into practice.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
限制临床试验参与者的权益。
赫尔辛基宣言》第 8 条要求,研究参与者的权益必须始终高于研究的科学利益。最近,有人建议对第 8 点进行反向修改,即科学利益高于参与者的利益是可以接受的。本文反对这一修改,并以 SARS-CoV-2 疫苗与安慰剂掩蔽试验为例进行论证。当疫苗的高疗效显现出来后,出现了一个问题:是继续进行掩蔽试验,直到获得长期疗效、免疫原性和安全性数据,还是打破掩蔽,向接受安慰剂的参与者提供已被证明有效的疫苗。后者是将第 8 点付诸实践的正确态度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2? The rights and interests of participants as limits to clinical trials. Artificial intelligence in clinical practice: Quality and evidence. Incidence of pregnancy related pulmonary embolism in Spain 2016-2021: an observational population-based retrospective study Soluble receptor for advanced glycation end-products positively correlated to kidney injury with coronary heart disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1